T. Rowe Price

With roughly $1.8T under management, T. Rowe Price ranks among the active investors in the AI space. That capital is deployed across their portfolio of AI-focused bets.

Across their portfolio, T. Rowe Price has consistently backed companies in AI, Tech, Healthcare, Finance. These focus areas reflect where the firm sees the strongest risk-adjusted returns in AI.

Awaira currently tracks 3 companies in T. Rowe Price's portfolio. The actual number may be higher, as some early-stage investments are not publicly disclosed.

The firm's sweet spot is Late Stage investing. That said, strong conviction deals can pull them into earlier or later rounds depending on the company.

The most notable deal on record for T. Rowe Price is T. Rowe Price is a growth-stage investment firm founded in 1937, headquartered in USA, managing approximately $1.8T in assets under management. The firm concentrates on AI, Tech, Healthcare, Finance, deploying capital primarily at the late stage level. Notable AI portfolio companies include OpenAI, SpaceX, Stripe. T. Rowe Price has participated in 4 funding rounds tracked by Awaira, deploying capital across AI, Tech, Healthcare sectors. The firm's investment strategy emphasizes AI applications in healthcare and life sciences. Awaira assigns T. Rowe Price an investor score of 82/100 based on portfolio strength, AI sector exposure, and market activity. The firm investment thesis centers on identifying AI companies that demonstrate strong technical moats, clear paths to revenue, and potential for category leadership within their respective segments. T. Rowe Price evaluates opportunities based on team quality, market timing, technology differentiation, and capital efficiency. Portfolio companies including OpenAI, SpaceX, Stripe reflect the firm emphasis on backing founders who combine deep technical expertise with commercial execution capability.. It is the kind of investment that defines a fund's reputation in the AI ecosystem.